Have you seen the latest news and insights on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: EU’s CHMP Backs Kalydeco, Symkevi License Extension for Use in Younger Children EU’s CHMP Backs Kalydeco, Symkevi License Extension for Use in Younger Children Sep 21, 2020 07:00 am | Marisa Wexler MS The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended extending the licenses for Symkevi and Kalydeco, two cystic fibrosis (CF) treatments marketed by Vertex Pharmaceuticals, to allow these medications to be used in younger children. If approved by the European Commission, these extensions would allow the use of Symkevi […] The post EU’s CHMP Backs Kalydeco, Symkevi License Extension for Use in Younger Children appeared first on Cystic Fibrosis News Today. Read More Recent News Moderna, Vertex Team Up to Develop Gene-editing Delivery Techniques For 7th Year, Bike 2 Breathe Hits Roads in Support of Those With CF Case Report Describes Unconventional Method for Delivering PERT in Premature CF Baby I’m Having Surgery (and Other Clickbait Headlines) Have Our Backs and Push Against Ableism With Us